Specialty Pharma Journal Specialty, Precision & Technology

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced positive subanalysis data of the Phase III lesinurad studies (CLEAR1, …

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that the U.S. Food and …

NEW YORK, Nov. 9, 2015 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP) (“Immune” or the “Company”) …

PHOENIX, Ariz. — Nov. 4, 2015 — A team of researchers, including scientists from the …

AstraZeneca announced today that it has entered into a definitive agreement to acquire ZS Pharma …

By introducing a particular strain of bacteria into the digestive tracts of mice with melanoma, …

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ:GILD) announced today that the U.S. Food and Drug …

PARIS and SEOUL, South Korea, Nov. 5, 2015 /PRNewswire-USNewswire/ — Sanofi and Hanmi Pharmaceutical Co., Ltd. …

NAPA, Calif. — Only 1 in 5 U.S. pancreatic cancer patients receive a widely available, …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Agilis Biotherapeutics, LLC (Agilis), a biotechnology company advancing innovative DNA therapeutics for rare …

WASHINGTON, DC (October 30, 2015) — The Biosimilars Council, a division of the Generic Pharmaceutical …

London, UK, 3 November 2015 – ViiV Healthcare, a global specialist HIV company with GSK, …

Despite a few years of good news with hepatitis C – with several new medications …

PARIS and MAINZ, Germany, November 3, 2015 /PRNewswire via COMTEX/ — Sanofi and BioNTech A.G. today …

By Kathleen P. Wolff, MBA Specialty Pharma Journal As consumers begin to adapt to the high …